Medpace

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Medpace and other ETFs, options, and stocks.

About MEDP

Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical, and medical device industries. The firm's services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance. 

CEO
August James Troendle
CEOAugust James Troendle
Employees
5,900
Employees5,900
Headquarters
Cincinnati, Ohio
HeadquartersCincinnati, Ohio
Founded
1992
Founded1992
Employees
5,900
Employees5,900

MEDP Key Statistics

Market cap
16.47B
Market cap16.47B
Price-Earnings ratio
40.91
Price-Earnings ratio40.91
Dividend yield
Dividend yield
Average volume
412.98K
Average volume412.98K
High today
$588.54
High today$588.54
Low today
$572.50
Low today$572.50
Open price
$580.37
Open price$580.37
Volume
220.08K
Volume220.08K
52 Week high
$625.00
52 Week high$625.00
52 Week low
$250.05
52 Week low$250.05

MEDP News

Simply Wall St 11h
This Insider Has Just Sold Shares In Medpace Holdings

We wouldn't blame Medpace Holdings, Inc. ( ) shareholders if they were a little worried about the fact that Susan Burwig, the Executive Vice President of Operat...

This Insider Has Just Sold Shares In Medpace Holdings
TipRanks 4d
Top Executives Cash In on Medpace Holdings Stock

New insider activity at Medpace Holdings ( (MEDP) ) has taken place on October 29, 2025. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at...

TipRanks 6d
Medpace and Telix Collaborate on Promising Phase 3 Study for Advanced Kidney Cancer

Medpace Holdings Inc ((MEDP)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% of...

Analyst ratings

58%

of 12 ratings
Buy
8.3%
Hold
58.3%
Sell
33.3%

More MEDP News

TipRanks 6d
Medpace and Radiopharm Launch Promising Cancer Study with 177LuBetaBart

Medpace Holdings Inc ((MEDP)), Radiopharm Theranostics Limited ((AU:RAD)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy:...

TipRanks 6d
Medpace and Radiopharm Theranostics Advance Brain Metastases Imaging Study

Medpace Holdings Inc ((MEDP)), Radiopharm Theranostics Limited ((AU:RAD)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy:...

TipRanks 6d
Tenax Therapeutics Advances Phase 3 Study on Levosimendan for PH-HFpEF

Tenax Therapeutics ((TENX)), Medpace Holdings Inc ((MEDP)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantag...

TipRanks 6d
Medpace Holdings Inc: A New Frontier in Carotid Artery Treatment

Medpace Holdings Inc ((MEDP)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50%...

People also own

Based on the portfolios of people who own MEDP. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.